Marilyn J. Telen

17.7k total citations
233 papers, 8.2k citations indexed

About

Marilyn J. Telen is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Marilyn J. Telen has authored 233 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Hematology, 141 papers in Genetics and 91 papers in Physiology. Recurrent topics in Marilyn J. Telen's work include Hemoglobinopathies and Related Disorders (136 papers), Erythrocyte Function and Pathophysiology (91 papers) and Blood groups and transfusion (90 papers). Marilyn J. Telen is often cited by papers focused on Hemoglobinopathies and Related Disorders (136 papers), Erythrocyte Function and Pathophysiology (91 papers) and Blood groups and transfusion (90 papers). Marilyn J. Telen collaborates with scholars based in United States, Canada and United Kingdom. Marilyn J. Telen's co-authors include Jen‐Tsan Chi, Laura M. De Castro, Allison E. Ashley‐Koch, Barton F. Haynes, Jude Jonassaint, Stephen M. Denning, Laura P. Hale, Carolyn Sangokoya, Melanie E. Garrett and AM Green and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Marilyn J. Telen

224 papers receiving 8.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn J. Telen United States 52 3.9k 3.8k 2.3k 2.2k 1.0k 233 8.2k
Fernando Ferreira Costa Brazil 41 4.2k 1.1× 4.5k 1.2× 1.7k 0.7× 2.0k 0.9× 397 0.4× 459 8.2k
Kevin Shannon United States 58 3.7k 1.0× 1.7k 0.5× 958 0.4× 6.2k 2.8× 1.6k 1.5× 276 12.5k
Mineo Kurokawa Japan 57 5.2k 1.3× 1.8k 0.5× 636 0.3× 6.0k 2.8× 1.8k 1.8× 455 12.8k
Giovanni Migliaccio Italy 46 2.4k 0.6× 1.8k 0.5× 1.2k 0.5× 2.5k 1.2× 1.1k 1.1× 190 7.2k
Elias Schwartz United States 35 2.7k 0.7× 2.7k 0.7× 714 0.3× 1.3k 0.6× 401 0.4× 148 5.4k
R.J. Arceci United States 62 3.1k 0.8× 973 0.3× 1.4k 0.6× 5.1k 2.4× 2.0k 1.9× 390 12.5k
Lars Kjeldsen Denmark 51 2.8k 0.7× 699 0.2× 905 0.4× 3.4k 1.6× 2.4k 2.3× 133 9.7k
Peter J. Lenting France 57 5.9k 1.5× 1.5k 0.4× 996 0.4× 1.8k 0.8× 2.2k 2.1× 208 10.0k
Wilma Barcellini Italy 42 3.1k 0.8× 1.6k 0.4× 2.5k 1.1× 582 0.3× 1.7k 1.6× 320 6.2k
Richard D. Brunning United States 43 7.4k 1.9× 3.7k 1.0× 693 0.3× 2.7k 1.2× 2.3k 2.2× 113 11.4k

Countries citing papers authored by Marilyn J. Telen

Since Specialization
Citations

This map shows the geographic impact of Marilyn J. Telen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn J. Telen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn J. Telen more than expected).

Fields of papers citing papers by Marilyn J. Telen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn J. Telen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn J. Telen. The network helps show where Marilyn J. Telen may publish in the future.

Co-authorship network of co-authors of Marilyn J. Telen

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn J. Telen. A scholar is included among the top collaborators of Marilyn J. Telen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn J. Telen. Marilyn J. Telen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telen, Marilyn J., et al.. (2024). 53 Systematic review of recipient alloimmunization using standard ABO+D versus an extended donor match protocol. American Journal of Obstetrics and Gynecology. 230(1). S41–S41. 1 indexed citations
2.
Saraf, Santosh L., Modupe Idowu, Ifeyinwa Osunkwo, et al.. (2024). Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease. Blood Advances. 8(16). 4459–4475. 7 indexed citations
3.
Lo, Ken Sin, Melanie E. Garrett, Carlo Brugnara, et al.. (2022). Variation and impact of polygenic hematologic traits in monogenic sickle cell disease. Haematologica. 108(3). 870–881. 9 indexed citations
4.
Silberstein, Leslie E. & Marilyn J. Telen. (2021). Update on the Cure Sickle Cell Initiative. The Hematologist. 18(2). 1 indexed citations
5.
6.
Dinardo, Carla Luana, Théo Gremen Mimary de Oliveira, Shannon Kelly, et al.. (2020). Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program. Transfusion. 61(2). 603–616. 9 indexed citations
7.
Telen, Marilyn J., Ted Wun, Timothy L. McCavit, et al.. (2015). Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood. 125(17). 2656–2664. 163 indexed citations
8.
Klings, Elizabeth S., Roberto F. Machado, Robyn J. Barst, et al.. (2014). An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 189(6). 727–740. 155 indexed citations
9.
Wun, Ted, Lori Styles, Laura DeCastro, et al.. (2014). Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia. PLoS ONE. 9(7). e101301–e101301. 52 indexed citations
10.
Galarneau, Geneviève, Sean Coady, Melanie E. Garrett, et al.. (2013). Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood. 122(3). 434–442. 25 indexed citations
11.
12.
LaMonte, Gregory, Nisha Philip, Joseph M. Reardon, et al.. (2012). Translocation of Sickle Cell Erythrocyte MicroRNAs into Plasmodium falciparum Inhibits Parasite Translation and Contributes to Malaria Resistance. Cell Host & Microbe. 12(2). 187–199. 235 indexed citations
13.
Zennadi, Rahima, et al.. (2008). Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium. Blood. 112(8). 3474–3483. 68 indexed citations
14.
Chen, Shaoyin, Yulei Wang, Marilyn J. Telen, & Jen‐Tsan Chi. (2008). The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases. PLoS ONE. 3(6). e2360–e2360. 157 indexed citations
15.
Bennett‐Guerrero, Elliott, Allan Doctor, Marilyn J. Telen, et al.. (2007). Evolution of adverse changes in stored RBCs. Proceedings of the National Academy of Sciences. 104(43). 17063–17068. 479 indexed citations
16.
Zen, Qin, Milena Batchvarova, Christine E. Eyler, et al.. (2004). B‐CAM/LU expression and the role of B‐CAM/LU activation in binding of low‐ and high‐density red cells to laminin in sickle cell disease. American Journal of Hematology. 75(2). 63–72. 27 indexed citations
17.
Kypson, Alan P., John J. Warner, Marilyn J. Telen, & Carmelo A. Milano. (2003). Paroxysmal cold hemoglobinuria and cardiopulmonary bypass. The Annals of Thoracic Surgery. 75(2). 579–581. 6 indexed citations
18.
Telen, Marilyn J.. (2000). Red blood cell surface adhesion molecules: Their possible roles in normal human physiology and disease. Seminars in Hematology. 37(2). 130–142. 77 indexed citations
19.
Telen, Marilyn J., et al.. (1999). Caring for patients with sickle cell disease in North Carolina.. PubMed. 60(1). 14–7. 1 indexed citations
20.
Lublin, DM, et al.. (1991). Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.. Journal of Clinical Investigation. 87(6). 1945–1952. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Ferreira Costa Breakdown of academic impact, for papers by Kevin Shannon Breakdown of academic impact, for papers by Mineo Kurokawa Breakdown of academic impact, for papers by Giovanni Migliaccio Breakdown of academic impact, for papers by Elias Schwartz Breakdown of academic impact, for papers by R.J. Arceci Breakdown of academic impact, for papers by Lars Kjeldsen Breakdown of academic impact, for papers by Peter J. Lenting Breakdown of academic impact, for papers by Wilma Barcellini Breakdown of academic impact, for papers by Richard D. Brunning
Rankless by CCL
2026